Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.
about
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective ImmunotherapyTrial Watch: Adoptive cell transfer for oncological indicationsPathways and therapeutic targets in melanomaClassification of current anticancer immunotherapiesPotential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes.PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.Cell transfer therapy for cancer: past, present, and future.Natural killer cells as a promising tool to tackle cancer-A review of sources, methodologies, and potentials.Immunotherapy for advanced melanoma: future directions.Novel immunotherapies for the treatment of melanoma.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
P2860
Q26771449-AE960690-FAE7-404C-B071-25475D9CCB39Q26785545-15478E62-FA3F-4DE9-B6AF-C6A28B1262C8Q26865736-5EB87A8C-8F24-4651-B2BB-DA29EFBE80A4Q35149637-4F0F9D5F-9DD8-47D8-8CFF-DCDB4901BA55Q36245682-71CD4898-6BDB-4501-B992-EF14525CC25FQ37565475-1F1AA4FC-A1CD-4D19-9EFF-B1851D674725Q38205228-9023B988-B0BF-447F-BCEE-E7FA3785152DQ38687810-3BB7B61A-4639-4CD2-BC41-753BAB945179Q38711163-38D42B7D-7344-47D3-A326-60528542CB53Q38824190-877BCC77-1E21-4338-9AEA-878037C21F14Q42702234-DDFC4678-9E4C-42AD-9D13-20647917051B
P2860
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of allogeneic NK c ...... clinical optimization studies.
@ast
Development of allogeneic NK c ...... clinical optimization studies.
@en
Development of allogeneic NK c ...... clinical optimization studies.
@nl
type
label
Development of allogeneic NK c ...... clinical optimization studies.
@ast
Development of allogeneic NK c ...... clinical optimization studies.
@en
Development of allogeneic NK c ...... clinical optimization studies.
@nl
prefLabel
Development of allogeneic NK c ...... clinical optimization studies.
@ast
Development of allogeneic NK c ...... clinical optimization studies.
@en
Development of allogeneic NK c ...... clinical optimization studies.
@nl
P2093
P2860
P1433
P1476
Development of allogeneic NK c ...... clinical optimization studies.
@en
P2093
Arnon Nagler
Gal Markel
Jacob Schachter
Michal J Besser
Naama Zabari
Orit Harari-Steinberg
Ron Loewenthal
Rona Ortenberg
Tsipi Shoham
P2860
P304
P356
10.1371/JOURNAL.PONE.0057922
P407
P577
2013-03-04T00:00:00Z